Seminars in Oncology
Volume 35 , Pages S28-S33 , June 2008

Pharmacokinetics, Metabolites, and Preclinical Safety of Vinflunine

  • Sharon Lobert

      Affiliations

    • University of Mississippi Medical Center, Jackson, MS.
    • ,
  • Christian Puozzo

      Affiliations

    • Institut de Recherche Pierre Fabre, Castres, France.
    • Corresponding Author InformationAddress correspondence to Christian Puozzo, PhD, Oncology Pharmacokinetic Department, Institut de Recherche Pierre Fabre, 2 rue Christian d'Espic, 81106 Castres, France

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr Lobert has received consulting fees from Bristol-Myers Squibb and has received research support from Pierre Fabre Oncologie. Dr Puozzo is an employee of the Institut de Recherche Pierre Fabre, a private pharmaceutical company supporting the development of vinflunine.

PII: S0093-7754(08)00020-1

doi: 10.1053/j.seminoncol.2008.01.007

Seminars in Oncology
Volume 35 , Pages S28-S33 , June 2008

Article Tools

* Image Usage & Resolution